Clinical Trial Update: TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

View source ↗

Summary

A clinical trial evaluating transarterial chemoembolization (TACE) in combination with PD-1/PD-L1 inhibitors and molecular-targeted therapies for intermediate-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhongda Hospital | Conditions: Hepatocellular Carcinoma | Status: COMPLETED